PRSBC and PRSER+ were associated with larger odds ratio estimates than PRSER- in predicting breast cancer risk, consistent with the fact that most breast cancers in men are ER positive, including those harboring BRCA1 and BRCA2 pathogenic variants (26). This evidence concerns the gene BRCA2 and breast cancer.